| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,312 |
3,137 |
$290K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,054 |
2,950 |
$265K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,620 |
1,518 |
$95K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
72 |
70 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
125 |
122 |
$5K |
| 90674 |
|
45 |
43 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
105 |
65 |
$920.30 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
54 |
52 |
$892.54 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
47 |
43 |
$354.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
15 |
$179.23 |
| 81003 |
|
62 |
62 |
$85.37 |
| 81000 |
|
25 |
25 |
$52.91 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
15 |
$1.22 |